Clinical Trials on Low-risk Breast Cancer
Total 11842 results
-
Institut Cancerologie de l'OuestActive, not recruitingMenopausal Patients | Low-risk Breast CancerFrance
-
Ostfold Hospital TrustUniversity of TromsoCompletedLow Risk Birth; Births With Low Risk FactorNorway
-
UNICANCERNational Cancer Institute, FranceRecruitingBreast Cancer | DCIS | Low Risk DCIS | Breast Conserving Surgery | Radiotherapy OmissionFrance
-
National Cancer Institute (NCI)CompletedRisk Reduction Behavior | High Risk for Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Adelphi University; Queen's Hospital CenterCompletedSurvey | Risk Perception | Cancer Related-Risks | Focus GroupUnited States
-
Far Eastern Memorial HospitalCompletedLow Risk PregnancyTaiwan
-
Centre Hospitalier Universitaire DijonTerminatedHigh Cardiovascular Risk Patients | Low Cardiovascular Risk PatientsFrance
-
Ambry GeneticsCompletedBreast Cancer RiskUnited States
-
University of Wisconsin, MadisonUnited States Department of DefenseCompletedBreast Cancer RiskUnited States
-
University of East AngliaQuadram Institute Bioscience; Clinical Research and Trials Unit (Norfolk &... and other collaboratorsCompleted
-
University of Illinois at ChicagoActive, not recruiting
-
Georgetown UniversityRecruiting
-
University of ManchesterManchester University NHS Foundation TrustCompleted
-
Columbia UniversityNational Cancer Institute (NCI); University of Wisconsin, Madison; National Institute...UnknownBreast Cancer RiskUnited States
-
Recep Tayyip Erdogan University Training and Research...CompletedHigh Caries Risk | Low Caries RiskTurkey
-
University Medical Center GroningenTerminatedHigh-Risk Breast CancerNetherlands
-
GI View Ltd.Terminated
-
University of RochesterCompletedLow Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors | Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk FactorsUnited States
-
Deborah Farr, MDRecruitingBreast Cancer | High Risk of Breast CancerUnited States
-
University of Illinois at ChicagoNational Cancer Institute (NCI)RecruitingHigh Risk for Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingHigh Risk for Developing Breast CancerUnited States
-
Precision Health Equity InitiativeNot yet recruiting
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Lawson Health Research InstituteRecruitingLocally Advanced Breast Cancer | High-Risk CancerCanada
-
Carol Fabian, MDActive, not recruitingIncreased Risk for Development of Breast CancerUnited States
-
Daiichi SankyoCompletedHER2-negative Breast Cancer | HER2-low Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingBreast Cancer | HER2-low Breast CancerChina
-
Jordan Collaborating Cardiology GroupThe Cardiovascular Academy Group of the JCS; The Jordan Cardiac Society (JCS); Istishari Hospital Department of Clinical ResearchTerminatedAtherosclerotic Cardiovascular Risk | Low-density-lipoprotein (LDL) CholesterolJordan
-
Raúl Sampieri CabreraCompletedStudents at Risk of Obtaining Low Academic PerformanceMexico
-
University of OxfordNational Institute for Health Research, United KingdomEnrolling by invitationBreast Cancer | Risk ReductionUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
Kathy MillerGenentech, Inc.RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-low Breast CancerUnited States
-
Reshma L. Mahtani, D.O.Gilead SciencesNot yet recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingER Positive/HER2 Low Breast CancerChina
-
University Hospital, GrenobleRecruitingRadiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation | Intermediate and High-risk Luminal and Triple Negative Breast CancerFrance
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer | Neoadjuvant Therapy | Hormone Receptor-positive Breast Cancer | HER2-low-expressing Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2 Low Advanced or Metastatic Breast Cancer
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
Royal Marsden NHS Foundation TrustNational Institute for Health Research, United KingdomActive, not recruitingBreast Cancer | Lifestyle Risk ReductionUnited Kingdom
-
Fudan UniversityRecruiting
-
Carol Fabian, MDBreast Cancer Research FoundationTerminatedFocus of Study is Healthy Women at Risk for Breast CancerUnited States
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Meir Medical CenterTel Aviv UniversityNot yet recruitingMalignant Tumor of Breast | Benign Breast Lumps | High-Risk Breast Cancer
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
NHS LothianNot yet recruitingLow Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate Cancer
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
UMC UtrechtCompletedBreast Cancer RiskNetherlands